DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value

$83.33+1.94 (+2.38%)

Close on Nov 13, 2026Market cap $31.08BP/E 32.8Yield –

DexCom enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

DexCom's enterprise value was $29.22B on Nov 11, 2026, against $22.92B a year earlier. Over the last 5 years it ranged from $21.67B to $50.73B, with a median of $31.46B.

Enterprise Value at the end of each year

Period	Period end	Value	Change
2026	Nov 11, 2026	$29.22B	+21.5%
2025	Dec 31, 2025	$24.05B	-14.4%
2024	Dec 31, 2024	$28.11B	-37.1%
2023	Dec 29, 2023	$44.70B	+8.1%
2022	Dec 30, 2022	$41.37B	-16.4%
2021	Dec 31, 2021	$49.50B	+42.2%
2020	Dec 31, 2020	$34.82B	+77.5%
2019	Dec 31, 2019	$19.62B	+96.8%
2018	Dec 31, 2018	$9.97B	+123.5%
2017	Dec 29, 2017	$4.46B	-9.3%
2016	Dec 30, 2016	$4.92B	-24.9%
2015	Dec 31, 2015	$6.55B	+58.4%
2014	Dec 31, 2014	$4.13B	+65.8%
2013	Dec 31, 2013	$2.49B	+180.6%
2012	Dec 31, 2012	$887.71M	+67.1%
2011	Dec 30, 2011	$531.11M	–